Hutch News
Results per Page:
Overcoming exhaustion: Engineered T-cells and pancreas cancer
From the Greenberg Lab, Clinical Research Division, Fred Hutch and the Stromnes Lab, University of Minnesota
Subverting the immunoproteasome in acute myeloid leukemia
From the Chapuis and Greenberg Labs, Clinical Research Division
Dr. Phil Greenberg becomes president-elect of American Association for Cancer Research
Immunologist looks ahead to international leadership role
Rewiring T cell death signaling enhances T cell function and persistence
From the Greenberg lab, Clinical Research Division
Adoptive transfer of engineered T cells prolongs survival in preclinical ovarian cancer
From the Greenberg lab, Clinical Research Division, and the Vaccine and Infectious Disease Division
WT1 T-cell Receptor Transduced T cells prevent AML relapse
From the Chapuis and Greenberg Labs, Clinical Research Division
Immunotherapy trailblazer Dr. Phil Greenberg to receive E. Donnall Thomas Lecture and Prize
American Society of Hematology honors his ‘vision, creativity and scientific rigor’ in T-cell therapy research
TCR-engineered T cell therapy enhanced by modulating macrophages
From the Hingorani and Greenberg Laboratories, Clinical Research Division
Timmerman headed for the top, again, with friends
Hutch expedition to Kilimanjaro has already raised $1 million
Dr. Kristin Anderson receives research grant from Ovarian Cancer Research Alliance
Anderson will use funds to expand research in boosting anti-tumor immune responses
From Everest to the snows of Kilimanjaro
Luke Timmerman's next mountain-climbing adventure to raise money for Fred Hutch cancer research
Hutch science featured at world's premier cancer immunotherapy meeting
Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer
Unleashing T cells for adoptive immunotherapy
from the Greenberg lab, Clinical Research Division
A Pathway to Independence Award for Dr. Amit Sharma
Celebrating faculty and staff achievements